2 -

2 - Eckardt JR, von Pawel J, Pujol JL et al. Phase III Study of Oral Compared With Intravenous Topotecan As Second-Line Therapy in Small-Cell Lung Cancer. J Clin Oncol 2007; 25(15):2086-2092.